Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2013 1
2014 1
2015 1
2016 2
2017 1
2018 1
2019 3
2020 4
2021 3
2022 1
2023 6
2024 5

Text availability

Article attribute

Article type

Publication date

Search Results

22 results

Results by year

Filters applied: . Clear all
Page 1
Pembrolizumab plus Chemotherapy in Lung Cancer.
Gil-Sierra MD, Fenix-Caballero S, Alegre-del Rey E. Gil-Sierra MD, et al. Among authors: fenix caballero s. N Engl J Med. 2018 Sep 13;379(11):e18. doi: 10.1056/NEJMc1808567. N Engl J Med. 2018. PMID: 30211498 No abstract available.
Response to the letter to the editor.
Olry de Labry Lima A, Fénix-Caballero S, Spacírova Z, Del Rey EJA. Olry de Labry Lima A, et al. Among authors: fenix caballero s. Breast. 2021 Dec;60:303. doi: 10.1016/j.breast.2021.10.008. Epub 2021 Oct 22. Breast. 2021. PMID: 34711467 Free PMC article. No abstract available.
Checklist for clinical applicability of subgroup analysis.
Gil-Sierra MD, Fénix-Caballero S, Abdel Kader-Martin L, Fraga-Fuentes MD, Sánchez-Hidalgo M, Alarcón de la Lastra-Romero C, Alegre-Del Rey EJ. Gil-Sierra MD, et al. Among authors: fenix caballero s. J Clin Pharm Ther. 2020 Jun;45(3):530-538. doi: 10.1111/jcpt.13102. Epub 2019 Dec 18. J Clin Pharm Ther. 2020. PMID: 31854128
Switching of anti-migraine antibodies: effectiveness or regression to the mean?
Alegre-Del Rey EJ, Fénix-Caballero S, Domínguez-Santana CM. Alegre-Del Rey EJ, et al. Among authors: fenix caballero s. Eur J Hosp Pharm. 2024 Feb 13:ejhpharm-2024-004102. doi: 10.1136/ejhpharm-2024-004102. Online ahead of print. Eur J Hosp Pharm. 2024. PMID: 38350696 No abstract available.
Abemaciclib as adjuvant treatment for high-risk early breast cancer.
Ganfornina Andrades A, Fénix Caballero S, Salguero Olid A, Alegre Del-Rey EJ. Ganfornina Andrades A, et al. Among authors: fenix caballero s. Farm Hosp. 2024 Mar-Apr;48(2):T75-T78. doi: 10.1016/j.farma.2023.10.010. Epub 2023 Dec 19. Farm Hosp. 2024. PMID: 38114413 Free article. Clinical Trial. English, Spanish.
Abemaciclib as adjuvant treatment for high-risk early breast cancer.
Ganfornina Andrades A, Fénix Caballero S, Salguero Olid A, Alegre Del-Rey Emilio J. Ganfornina Andrades A, et al. Among authors: fenix caballero s. Farm Hosp. 2024 Mar-Apr;48(2):75-78. doi: 10.1016/j.farma.2023.08.006. Epub 2023 Sep 19. Farm Hosp. 2024. PMID: 37735004 Free article. Clinical Trial. English, Spanish.
22 results